Standex Sales Soar 27.5%, But Net Income Dips on Higher Costs

TL;DR

**SXI's top-line growth is impressive, but soaring interest expenses and restructuring costs are eating into profits, making it a hold until they get debt under control.**

AI Summary

STANDEX INTERNATIONAL CORP/DE/ reported a mixed financial performance for the three months ended September 30, 2025. Net sales increased significantly to $217.43 million, up from $170.46 million in the prior year, representing a 27.5% increase. However, net income attributable to Standex International Corporation decreased to $15.06 million, down from $18.20 million in the same period last year, a 17.3% decline. This reduction in net income was primarily driven by a substantial increase in interest expense, which surged to $8.91 million from $0.98 million, and higher restructuring costs of $5.997 million compared to $1.086 million. The company also saw a negative foreign currency translation adjustment of $15.27 million, contributing to a total comprehensive income attributable to Standex of only $0.64 million, a sharp drop from $40.21 million in the prior year. The acquisition of McStarlite for $57.0 million on February 5, 2025, a provider of aerospace components, is a key business change, adding $16.2 million in goodwill and $24.5 million in identifiable intangible assets. Total assets decreased slightly to $1,554.86 million from $1,566.88 million at June 30, 2025, while long-term debt decreased to $544.62 million from $552.52 million.

Why It Matters

For investors, the significant increase in net sales by 27.5% to $217.43 million indicates strong top-line growth, potentially driven by strategic acquisitions like McStarlite. However, the 17.3% decline in net income to $15.06 million, largely due to a massive 811% jump in interest expense and increased restructuring costs, signals profitability pressures and higher debt servicing burdens. This could impact dividend sustainability and future share buybacks, making SXI less attractive compared to competitors with more stable profit margins. Employees might face uncertainty due to ongoing restructuring efforts, while customers could benefit from expanded product offerings through acquisitions in the Engineering Technologies segment.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant increase in interest expense from $0.98 million in Q3 2024 to $8.91 million in Q3 2025, an 811% jump, which heavily impacted net income. Additionally, restructuring costs rose from $1.086 million to $5.997 million, indicating ongoing operational adjustments that could create short-term volatility.

Analyst Insight

Investors should closely monitor STANDEX INTERNATIONAL CORP/DE/'s debt management strategies and the impact of recent acquisitions on future profitability. While sales growth is positive, the substantial increase in interest expense warrants caution; consider holding SXI until there's clear evidence of improved net income and reduced debt servicing costs.

Financial Highlights

debt To Equity

0.77

revenue

$217.43M

operating Margin

13.6%

total Assets

$1,554.86M

total Debt

$544.62M

net Income

$15.06M

eps

$1.25

gross Margin

41.6%

cash Position

$98.65M

revenue Growth

+27.5%

Key Numbers

• $217.43M — Net Sales (Increased 27.5% from $170.46M in Q3 2024 to $217.43M in Q3 2025.)
• $15.06M — Net Income Attributable to Standex (Decreased 17.3% from $18.20M in Q3 2024 to $15.06M in Q3 2025.)
• $8.91M — Interest Expense (Increased 811% from $0.98M in Q3 2024 to $8.91M in Q3 2025.)
• $5.997M — Restructuring Costs (Increased from $1.086M in Q3 2024 to $5.997M in Q3 2025.)
• $57.0M — McStarlite Acquisition Price (Net cash paid for 100% of McStarlite on February 5, 2025.)
• $1.25 — Diluted EPS (Decreased from $1.53 in Q3 2024 to $1.25 in Q3 2025.)
• $544.62M — Long-term Debt (Decreased from $552.52M at June 30, 2025 to $544.62M at September 30, 2025.)
• $15.27M — Foreign Currency Translation Loss (Negative impact on comprehensive income in Q3 2025, compared to a gain of $23.01M in Q3 2024.)

Key Players & Entities

• STANDEX INTERNATIONAL CORP/DE/ (company) — registrant
• McStarlite (company) — acquired company
• Basmat Inc. (company) — dba McStarlite
• New York Stock Exchange (regulator) — exchange where SXI is registered
• $217,431 (dollar_amount) — net sales for Q3 2025
• $170,464 (dollar_amount) — net sales for Q3 2024
• $15,056 (dollar_amount) — net income attributable to Standex International Corporation for Q3 2025
• $18,197 (dollar_amount) — net income attributable to Standex International Corporation for Q3 2024
• $8,912 (dollar_amount) — interest expense for Q3 2025
• $977 (dollar_amount) — interest expense for Q3 2024

FAQ

Risk Factors

• Increased Interest Expense [high — financial]: Interest expense surged by 811% from $0.98 million in Q3 2024 to $8.91 million in Q3 2025. This significant increase negatively impacted net income, contributing to a 17.3% decline despite a substantial rise in net sales.
• Elevated Restructuring Costs [medium — operational]: Restructuring costs increased by 453% from $1.086 million in Q3 2024 to $5.997 million in Q3 2025. These higher costs, alongside increased interest expense, were primary drivers for the decrease in net income.
• Negative Foreign Currency Translation [medium — financial]: The company experienced a negative foreign currency translation adjustment of $15.27 million in Q3 2025. This contrasts with a positive adjustment in the prior year and significantly reduced total comprehensive income.
• Acquisition Integration and Goodwill [medium — financial]: The acquisition of McStarlite for $57.0 million added $16.2 million in goodwill and $24.5 million in identifiable intangible assets. While strategic, the integration and ongoing amortization of intangibles can impact future profitability.

Industry Context

Standex operates in diverse industrial markets, including aerospace, electronics, and food service equipment. The company faces competition from both large conglomerates and specialized niche players. Recent trends indicate a demand for advanced materials and components, particularly in the aerospace sector, which the McStarlite acquisition aims to capitalize on.

Regulatory Implications

As a publicly traded company, Standex is subject to SEC regulations and accounting standards (GAAP). Compliance with financial reporting requirements is crucial. Potential risks include evolving environmental regulations impacting manufacturing processes and international trade policies affecting global sales and supply chains.

What Investors Should Do

1. Monitor interest expense trends
2. Assess acquisition integration success
3. Evaluate foreign currency impact
4. Analyze restructuring cost drivers

Key Dates

• 2025-02-05: Acquisition of McStarlite — This strategic acquisition in the aerospace components sector aims to expand the company's offerings, though it introduced integration costs and goodwill.
• 2025-09-30: End of Q3 2025 — Reporting period for the 10-Q, showing significant revenue growth but a decline in net income due to increased expenses and foreign currency impacts.

Glossary

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (The McStarlite acquisition added $16.2 million in goodwill, impacting the balance sheet and potentially subject to impairment testing.)

Intangible assets, net

Non-physical assets that have value, such as patents, trademarks, and customer lists, net of accumulated amortization. (The McStarlite acquisition added $24.5 million in identifiable intangible assets, which will be amortized over their useful lives, affecting future expenses.)

Total comprehensive income

The change in equity of a business during a period from transactions and other events and circumstances from non-owner sources. It includes net income plus other comprehensive income (or loss). (Standex reported a significantly lower total comprehensive income of $0.64 million compared to $40.21 million in the prior year, largely due to foreign currency translation adjustments.)

Foreign currency translation adjustment

Gains or losses that result from translating the financial statements of a foreign subsidiary into the parent company's reporting currency. (A negative adjustment of $15.27 million in the current quarter significantly reduced comprehensive income.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, Standex International Corp. reported a strong 27.5% increase in net sales to $217.43 million. However, net income attributable to Standex decreased by 17.3% to $15.06 million. This divergence was primarily driven by a substantial 811% surge in interest expense to $8.91 million and a more than five-fold increase in restructuring costs to $5.997 million. Additionally, a significant negative foreign currency translation adjustment of $15.27 million negatively impacted total comprehensive income, which fell sharply from $40.21 million to $0.64 million.

Key Financial Figures

• $1.50 — ich registered Common Stock, Par Value $1.50 Per Share SXI New York Stock Exchan

Filing Documents

• sxi20250930_10q.htm (10-Q) — 1496KB
• ex_865566.htm (EX-31.1) — 12KB
• ex_865567.htm (EX-31.2) — 12KB
• ex_865568.htm (EX-32) — 12KB
• 0001437749-25-032584.txt ( ) — 8431KB
• sxi-20250930.xsd (EX-101.SCH) — 71KB
• sxi-20250930_cal.xml (EX-101.CAL) — 78KB
• sxi-20250930_def.xml (EX-101.DEF) — 460KB
• sxi-20250930_lab.xml (EX-101.LAB) — 397KB
• sxi-20250930_pre.xml (EX-101.PRE) — 506KB
• sxi20250930_10q_htm.xml (XML) — 1543KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION: Item 1. Condensed Consolidated Balance Sheets as of September 30, 2025 and June 30, 2025 (unaudited) 3 Condensed Consolidated Statements of Operations for the three months ended September 30, 2025 and 2024 (unaudited) 4 Condensed Consolidated Statements of Comprehensive Income for the three months ended September 30, 2025 and 2024 (unaudited) 5 Condensed Consolidated Statements of Stockholders' Equity for the three months ended September 30, 2025 and 2024 (unaudited) 6 Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2025 and 2024 (unaudited) 7 Notes to Unaudited Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 34 Item 4.

Controls and Procedures

Controls and Procedures 35

OTHER INFORMATION

PART II. OTHER INFORMATION: Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36 Item 5. Other Information 36 Item 6. Exhibits 37 2

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION ITEM 1 STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES Unaudited Condensed Consolidated Balance Sheets (In thousands, except share and per share data) September 30, 2025 June 30, 2025 ASSETS Current assets: Cash and cash equivalents $ 98,653 $ 104,542 Accounts receivable, less allowance for credit losses of $ 3,807 and $ 3,985 at September 30, 2025 and June 30, 2025, respectively 166,668 172,702 Inventories 135,777 129,994 Contract assets 64,237 59,228 Prepaid expenses and other current assets 22,238 14,413 Total current assets 487,573 480,879 Property, plant, and equipment, net 159,596 160,364 Intangible assets, net 218,164 225,757 Goodwill 599,923 610,338 Deferred tax asset 11,522 11,971 Operating lease right-of-use asset 46,950 47,998 Other non-current assets 31,136 29,573 Total non-current assets 1,067,291 1,086,001 Total assets $ 1,554,864 $ 1,566,880 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 87,704 $ 88,001 Accrued liabilities 66,654 63,204 Income taxes payable 15,339 15,770 Total current liabilities 169,697 166,975 Long-term debt 544,623 552,515 Operating lease long-term liabilities 38,399 40,057 Accrued pension and other non-current liabilities 67,337 67,743 Total non-current liabilities 650,359 660,315 Contingencies (Note 15) Redeemable noncontrolling interest 27,149 27,913 Stockholders' equity: Common stock, par value $ 1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 12,033,324 and 11,992,116 shares outstanding at September 30, 2025 and June 30, 2025 41,976 41,976 Additional paid-in capital 137,415 136,082 Retained earnings 1,138,071 1,126,851 Accumulated other comprehensive loss ( 179,185 ) ( 164,765 ) Treasury shares: 15,950,954 and 15,992,162 shares at September 30, 2025 and June 30, 2025 ( 430,618 ) ( 428,467 ) Total stockholders' equity 707,659 711,677 To

View Full Filing

View this 10-Q filing on SEC EDGAR